A young woman in Los Angeles, USA, says a rare condition causes her eye to “bulge” when she chews, but she has turned down ...

A generally healthy 63-year-old man in the New England area went to the hospital with a fever, cough, and vision problems in ...

A new study warns that a widely used eye ointment can damage a popular glaucoma implant. Researchers found that oil-based ...

A Guide to Dog Eye Health Issues Key Points Concerning eye problems in dogs may appear as redness, discharge, or behaviors ...

Graves' disease, an autoimmune thyroid disorder, is being diagnosed more often among young adults. Doctors explain symptoms, ...

During a Senate Appropriations Committee hearing earlier this year in May, FBI Director Kash Patel made a jerk out of himself by trying to intimidate Senator Patty Murray (D-WA), who called him out ...

The American Heart Association says upcoming family holiday gatherings are a good time to talk about your family health history and how it can play an important role in heart disease. Research shows ...

An estimated 5-15% of people have problems with dry eyes, with symptoms including eye redness, stinging, or burning sensation, and eye fatigue. Dry eye disease (DED) occurs when the eyes' tear glands ...

Argenx SE (NASDAQ: ARGX) on Monday announced it would discontinue the Phase 3 UplighTED studies evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with ...

While argenx has been able to demonstrate the merit of its FcRn drug Vyvgart in multiple autoimmune indications, not every shot in the clinic is destined to land. Now, facing that fact in thyroid eye ...

Shares in argenx fell after the pharmaceutical company said it would stop late-stage trials for an experimental drug to treat thyroid eye disease due to lack of efficacy. In European afternoon trading ...

Four patients who developed a serious eye disease after using Novo Nordisk A/S’s blockbuster weight-loss drugs have been granted compensation in Denmark, the drugmaker’s home market. The claimants ...